摘要 |
The present invention relates to heterocyclic compounds represented by the formula I or pharmaceutically acceptable salts thereof and antitumor agents containing the heterocyclic compounds as effective components: wherein X represents nitrogen atom or CH; R<SUB>1 </SUB>represents CH<SUB>n</SUB>F<SUB>3-n </SUB>(wherein n is 1 or 2), hydroxy C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl, NHR<SUB>6 </SUB>[wherein R<SUB>6 </SUB>represents hydrogen atom or COR (wherein R represents hydrogen atom, C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl or C<SUB>1</SUB>-C<SUB>6 </SUB>alkoxy)]; R<SUB>2 </SUB>represents morpholino (which may be substituted with one to four C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl), thiomorpholino, piperidino, pyrrolidinyl (which may be substituted with hydroxy C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl), oxazolidinyl (which may be substituted with one or two C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl) or tetrahydro-1,4-thiazin-1-oxo-4-yl; R<SUB>3 </SUB>and R<SUB>4 </SUB>each represent hydrogen atom or C<SUB>1</SUB>-C<SUB>6 </SUB>alkyl; and R<SUB>5 </SUB>represents hydrogen atom, amino or hydroxyl.
|